nib has announced an 11.1 per cent increase in underlying operating profit for the 12 months to 20 June 2023.
Latest Video
New Stories
-
Australian company reports high response rate in trial of off-the-shelf CAR-T therapy
December 1, 2025 - -
Melbourne showcases its health and biomedical strength as leaders gather for National Precincts Summit
December 1, 2025 - - Australian Biotech -
Pharmac to expand emergency medicine access for rural and remote communities
December 1, 2025 - - Latest News -
Tetratherix joint venture secures Alcon partnership to accelerate ophthalmic biomaterials
December 1, 2025 - - Australian Biotech -
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 - - Latest News -
New PBS listing offers fresh hope for Australians living with debilitating skin condition
December 1, 2025 - - Latest News -
Five Australians honoured for leadership and community advocacy in evolving HIV response
December 1, 2025 - - Latest News
